34 related articles for article (PubMed ID: 34161675)
1. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
[TBL] [Abstract][Full Text] [Related]
3. Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes.
Winter S; Fisel P; Büttner F; Rausch S; D'Amico D; Hennenlotter J; Kruck S; Nies AT; Stenzl A; Junker K; Scharpf M; Hofmann U; van der Kuip H; Fend F; Ott G; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
Sci Rep; 2016 Jul; 6():29930. PubMed ID: 27435027
[TBL] [Abstract][Full Text] [Related]
4. ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis.
Li L; Gong Y; Tang J; Yan C; Li L; Peng W; Cheng Z; Yu R; Xiang Q; Deng C; Mu J; Xia J; Luo X; Wu Y; Xiang T
Cell Mol Life Sci; 2022 Jan; 79(2):83. PubMed ID: 35048182
[TBL] [Abstract][Full Text] [Related]
5. PRDM16 suppresses HIF-targeted gene expression in kidney cancer.
Kundu A; Nam H; Shelar S; Chandrashekar DS; Brinkley G; Karki S; Mitchell T; Livi CB; Buckhaults P; Kirkman R; Tang Y; Rowe GC; Wei S; Varambally S; Sudarshan S
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32251515
[TBL] [Abstract][Full Text] [Related]
6. Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma.
Faraj Tabrizi P; Peters I; Schimansky I; Dubrowinskaja N; Reese C; Tezval H; Kuczyk MA; Serth J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003666
[TBL] [Abstract][Full Text] [Related]
7. The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma.
Lameirinhas A; Miranda-Gonçalves V; Henrique R; Jerónimo C
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30986931
[TBL] [Abstract][Full Text] [Related]
8. Bovine Meat and Milk Factor-like Sequences Are Frequently Detected in Renal Cell Carcinoma Tissues.
Mobaraki G; Shi S; Smits KM; Severens K; Lommen K; Rennspiess D; Chteinberg E; Winnepenninckx V; Samarska I; Klufah F; Hausen AZ
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730698
[TBL] [Abstract][Full Text] [Related]
9. The Advances in Epigenetics for Cancer Radiotherapy.
Wang Y; Han Y; Jin Y; He Q; Wang Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628460
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations during renal carcinogenesis.
Arai E; Kanai Y
Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
[TBL] [Abstract][Full Text] [Related]
11. An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma.
Grammatikaki S; Katifelis H; Farooqi AA; Stravodimos K; Karamouzis MV; Souliotis K; Varvaras D; Gazouli M
In Vivo; 2023; 37(1):1-10. PubMed ID: 36593023
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of ZBTB28 promotes renal cell carcinogenesis.
Tong X; Xu L; Rong R; Su X; Xiang T; Peng W; Shi T
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e79-e86. PubMed ID: 34161675
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.
Xiang T; Tang J; Li L; Peng W; Du Z; Wang X; Li Q; Xu H; Xiong L; Xu C; Le X; Wei X; Yu F; Li S; Xiao Q; Luo B; Xiang X; Huang A; Lin Y; Ren G; Tao Q
Theranostics; 2019; 9(26):8182-8195. PubMed ID: 31754389
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of HOXA11, a novel functional tumor suppressor for renal cell carcinoma, is associated with RCC TNM classification.
Wang L; Cui Y; Sheng J; Yang Y; Kuang G; Fan Y; Jin J; Zhang Q
Oncotarget; 2017 Mar; 8(13):21861-21870. PubMed ID: 28423531
[TBL] [Abstract][Full Text] [Related]
15. Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency.
Zhou H; Guo L; Yao W; Shi R; Yu G; Xu H; Ye Z
J Cell Physiol; 2020 Mar; 235(3):2113-2128. PubMed ID: 31432508
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]